BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bloomgarden ZT, Inzucchi SE, Karnieli E, Le Roith D. The proposed terminology ‘A(1c)-derived average glucose’ is inherently imprecise and should not be adopted. Diabetologia. 2008;51:1111-1114. [PMID: 18449525 DOI: 10.1007/s00125-008-1027-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Raghubeer S, Matshazi DM, Motshwari DD, Weale CJ, Erasmus RT, Matsha TE. The Role of Glycated Albumin as a Biomarker of Glycemic Control in Diabetes and Chronic Kidney Disease. Biomarkers in Diabetes 2023. [DOI: 10.1007/978-3-031-08014-2_61] [Reference Citation Analysis]
2 Raghubeer S, Matshazi DM, Motshwari DD, Weale CJ, Erasmus RT, Matsha TE. The Role of Glycated Albumin as a Biomarker of Glycemic Control in Diabetes and Chronic Kidney Disease. Biomarkers in Diabetes 2022. [DOI: 10.1007/978-3-030-81303-1_61-1] [Reference Citation Analysis]
3 Trocmé C, Gonnet N, Di Tommaso M, Samouda H, Cracowski JL, Cracowski C, Lambert-Porcheron S, Laville M, Nobécourt E, Gaddhab C, Le Lay A, Bohn T, Poitou C, Clément K, Al-Mulla F, Bitar MS, Bottari SP. Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes? Front Mol Biosci 2020;7:596141. [PMID: 33665204 DOI: 10.3389/fmolb.2020.596141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Luo M, Kong X, Wang H, Zhai X, Cai T, Ding B, Hu Y, Jing T, Su X, Li H, Ma J. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs. J Diabetes Res 2020;2020:6666403. [PMID: 33299890 DOI: 10.1155/2020/6666403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Desouza CV, Holcomb RG, Rosenstock J, Frias JP, Hsia SH, Klein EJ, Zhou R, Kohzuma T, Fonseca VA. Results of a study comparing glycated albumin to other glycemic indices. J Clin Endocrinol Metab. 2020;105. [PMID: 31650161 DOI: 10.1210/clinem/dgz087] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
6 Bloomgarden Z. Beyond HbA1c, second take. Journal of Diabetes 2019;11:416-417. [DOI: 10.1111/1753-0407.12910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Ramachandra Bhat L, Vedantham S, Krishnan UM, Rayappan JBB. Methylglyoxal – An emerging biomarker for diabetes mellitus diagnosis and its detection methods. Biosensors and Bioelectronics 2019;133:107-24. [DOI: 10.1016/j.bios.2019.03.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
8 Bloomgarden Z. Beyond HbA1c. J Diabetes 2017;9:1052-3. [PMID: 28792665 DOI: 10.1111/1753-0407.12590] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bloomgarden Z, Ning G. Self-monitoring of blood glucose for type 2 diabetes. Journal of Diabetes 2015;7:593-594. [DOI: 10.1111/1753-0407.12307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Desouza CV, Rosenstock J, Zhou R, Holcomb RG, Fonseca VA. GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS. Endocr Pract 2015;21:1195-203. [PMID: 26214108 DOI: 10.4158/EP14570.OR] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
11 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 257] [Article Influence: 34.7] [Reference Citation Analysis]
12 Williams ME. Hemoglobin A1c in the ESRD Population: Status Report. Semin Dial 2014;27:559-62. [DOI: 10.1111/sdi.12276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
13 Florkowski C, Crooke M, Reed M. Implementation of the HbA1c IFCC unit — from the laboratory to the consumer: The New Zealand experience. Clinica Chimica Acta 2014;432:157-61. [DOI: 10.1016/j.cca.2013.10.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, Drechsler C, Lacatus R, Vanholder R, Nistor I, Bilo H, Bolignano D, Couchoud C, Covic A, Coentrao L, Sutter JD, Drechsler C, Gnudi L, Goldsmith D, Heaf J, Heimburger O, Jager K, Nacak H, Nistor I, Soler M, Tomson C, Vanhuffel L, Biesen WV, Laecke SV, Weekers L, Wiecek A; for the European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrology Dialysis Transplantation 2014;29:2167-77. [DOI: 10.1093/ndt/gfu006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 74] [Article Influence: 8.3] [Reference Citation Analysis]
15 Huang H, Peng G, Lin M, Zhang K, Wang Y, Yang Y, Zuo Z, Chen R, Wang J. The diagnostic threshold of HbA1c and impact of its use on diabetes prevalence—A population-based survey of 6898 Han participants from southern China. Preventive Medicine 2013;57:345-50. [DOI: 10.1016/j.ypmed.2013.06.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
16 Peng G, Lin M, Zhang K, Chen J, Wang Y, Yang Y, Wang J, Huang H. Hemoglobin A1c can identify more cardiovascular and metabolic risk profile in OGTT-negative Chinese population. Int J Med Sci 2013;10:1028-34. [PMID: 23801890 DOI: 10.7150/ijms.5905] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
17 Wolffenbuttel BH, Herman WH, Gross JL, Dharmalingam M, Jiang HH, Hardin DS. Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care 2013;36:2931-6. [PMID: 23757434 DOI: 10.2337/dc12-2711] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
18 Sacks DB. Measurement of hemoglobin A(1c): a new twist on the path to harmony. Diabetes Care. 2012;35:2674-2680. [PMID: 23173136 DOI: 10.2337/dc12-1348] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 9.3] [Reference Citation Analysis]
19 Aldasouqi SA, Gossain VV. Update on diabetes diagnosis: a historical review of the dilemma of the diagnostic utility of glycohemoglobin A1c and a proposal for a combined glucose-A1c diagnostic method. Ann Saudi Med 2012;32:229-35. [PMID: 22588455 DOI: 10.5144/0256-4947.2012.229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
20 Bloomgarden ZT, Drexler A. Is there a U-shaped curve of A1c versus mortality? J Diabetes 2012;4:107-8. [PMID: 22443259 DOI: 10.1111/j.1753-0407.2012.00199.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Glesby MJ, Hoover DR, Shi Q, Danoff A, Howard A, Tien P, Merenstein D, Cohen M, Golub E, Dehovitz J, Nowicki M, Anastos K. Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study. Antivir Ther 2010;15:571-7. [PMID: 20587850 DOI: 10.3851/IMP1557] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
22 Bloomgarden Z. Troubling ethical questions from gestational diabetes trial. J Diabetes 2010;2:1-4. [PMID: 20923469 DOI: 10.1111/j.1753-0407.2009.00059.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
23 Lipska KJ, De Rekeneire N, Van Ness PH, Johnson KC, Kanaya A, Koster A, Strotmeyer ES, Goodpaster BH, Harris T, Gill TM. Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab. 2010;95:5289-5295. [PMID: 20861123 DOI: 10.1210/jc.2010-1171] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 6.9] [Reference Citation Analysis]
24 Lippi G, Targher G. Glycated hemoglobin (HbA1c): old dogmas, a new perspective? Clin Chem Lab Med. 2010;48:609-614. [PMID: 20464776 DOI: 10.1515/cclm.2010.144] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
25 Hempe JM, Soros AA, Chalew SA. Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control. Diabetes Care 2010;33:1449-51. [PMID: 20357368 DOI: 10.2337/dc09-1498] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
26 Bloomgarden ZT. A1C: recommendations, debates, and questions. Diabetes Care 2009;32:e141-7. [PMID: 19940210 DOI: 10.2337/dc09-zb12] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
27 Escribano-serrano J, García-domínguez L, Díaz-pintado M. Glucohemoglobina. Tercera parte: interpretarla. SEMERGEN - Medicina de Familia 2010;36:95-9. [DOI: 10.1016/j.semerg.2009.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Shrom D, Sarwat S, Ilag L, Bloomgarden ZT. Does A1c consistently reflect mean plasma glucose?: A1c versus mean plasma glucose. Journal of Diabetes 2010;2:92-6. [DOI: 10.1111/j.1753-0407.2010.00066.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
29 Dankner R, Danoff A, Roth J. Can ‘ personalized diagnostics ’ promote earlier intervention for dysglycaemia? Hypothesis ready for testing. Diabetes Metab Res Rev 2010;26:7-9. [DOI: 10.1002/dmrr.1039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bloomgarden ZT, Einhorn D. Hemoglobin A1C in Diabetes Diagnosis: Time for Caution. Endocrine Practice 2010;16:5-6. [DOI: 10.4158/ep.16.1.5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
31 Bloomgarden ZT. Diabetes treatment and measures of glycemia. Diabetes Care 2009;32:e39-43. [PMID: 19336631 DOI: 10.2337/dc09-zb04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Little RR, Sacks DB. HbA1c: how do we measure it and what does it mean?: . Current Opinion in Endocrinology, Diabetes and Obesity 2009;16:113-8. [DOI: 10.1097/med.0b013e328327728d] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 5.8] [Reference Citation Analysis]
33 Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A1c in the management of diabetes: A1c in the management of diabetes. Journal of Diabetes 2009;1:9-17. [DOI: 10.1111/j.1753-0407.2009.00009.x] [Cited by in Crossref: 177] [Cited by in F6Publishing: 189] [Article Influence: 13.6] [Reference Citation Analysis]
34 Gillery P. Hémoglobine glyquée. EMC - Biologie médicale 2009;4:1-6. [DOI: 10.1016/s2211-9698(09)71412-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 John Wiley & Sons, Ltd. Current literature in diabetes. Diabetes Metab Res Rev 2009;25:i-x. [DOI: 10.1002/dmrr.930] [Reference Citation Analysis]
36 Haugaard SB, Madsbad S, Mølvig J. The proposed terminology 'A1c-derived average glucose' is inherently imprecise and should not be adopted. Reply to Bloomgarden ZT, Inzucchi SE, Karnieli E, et al. Diabetologia 2009;52:547-9. [PMID: 19066843 DOI: 10.1007/s00125-008-1234-2] [Reference Citation Analysis]
37 Bloomgarden ZT. American College Of Endocrinology Pre-Diabetes Consensus Conference: part one. Diabetes Care. 2008;31:2062-2069. [PMID: 18820229 DOI: 10.2337/dc08-zb10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
38 Bloomgarden ZT. Approaches to treatment of type 2 diabetes. Diabetes Care 2008;31:1697-703. [PMID: 18663234 DOI: 10.2337/dc08-zb08] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]